inventions and patents

Nestlé Creates Sweeter-Tasting Sugar, So It Can Use Less

The new product is sugar, but is made differently so less goes into the stomach, but users still get the sweet taste.

Nestlé Creates Sweeter-Tasting Sugar, So It Can Use Less

The new product is sugar, but is made differently so less goes into the stomach, but users still get the sweet taste.

Nestlé Creates Sweeter-Tasting Sugar, So It Can Use Less

The new product is sugar, but is made differently so less goes into the stomach, but users still get the sweet taste.

Nestlé Reformulates Sugar and Says It Will Use Less in Its Candy

The new product is sugar, but is made differently so less goes into the stomach but consumers still get the sweet taste.

Nestlé Reformulates Sugar and Says It Will Use Less in Its Candy

The new product is sugar, but is made differently so less goes into the stomach but consumers still get the sweet taste.

Nestlé Reformulates Sugar and Says It Will Use Less in Its Candy

The new product is sugar, but is made differently so less goes into the stomach but consumers still get the sweet taste.

Supreme Court to Hear Printer Cartridge Patent Case

Impression Products has been buying Lexmark ink cartridges to refill and resell them. Lexmark claims this infringes its patents.
Supreme Court Gives Samsung a Reprieve in Apple Patent Case

Supreme Court Gives Samsung a Reprieve in Apple Patent Case

Kathleen M. Sullivan, a lawyer for Samsung, outside the Supreme Court building in October. The court ruled on Tuesday that Samsung may not have to give up $399 million for copying parts of the
Supreme Court Gives Samsung a Reprieve in Apple Patent Case

Supreme Court Gives Samsung a Reprieve in Apple Patent Case

Kathleen M. Sullivan, a lawyer for Samsung, outside the Supreme Court building in October. The court ruled on Tuesday that Samsung may not have to give up $399 million for copying parts of the
Retro Report: Lives and Profits in the Balance: The High Stakes of Medical Patents

Retro Report: Lives and Profits in the Balance: The High Stakes of Medical Patents

Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, departs after appearing before a House Oversight and Government Reform hearing on “Developments in the Prescription Drug Market Oversight” on
Retro Report: Lives and Profits in the Balance: The High Stakes of Medical Patents

Retro Report: Lives and Profits in the Balance: The High Stakes of Medical Patents

Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, departs after appearing before a House Oversight and Government Reform hearing on “Developments in the Prescription Drug Market Oversight” on

‘Could You Patent the Sun?’

Decades after Dr. Jonas Salk opposed patenting the polio vaccine, the pharmaceutical industry has changed. What does that mean for the development of innovative drugs and for people whose lives depend
Retro Report: Lives and Profits in the Balance: The High Stakes of Medical Patents

Retro Report: Lives and Profits in the Balance: The High Stakes of Medical Patents

Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, departs after appearing before a House Oversight and Government Reform hearing on “Developments in the Prescription Drug Market Oversight” on
Public Labs, Corporate Gains: Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Public Labs, Corporate Gains: Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Dr. Steven Rosenberg, left, who has led the surgery branch at the National Cancer Institute for 42 years, and Dr. Arie Belldegrun, the founder of Kite Pharma.
Public Labs, Corporate Gains: Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Public Labs, Corporate Gains: Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Dr. Steven Rosenberg, left, who has led the surgery branch at the National Cancer Institute for 42 years, and Dr. Arie Belldegrun, the founder of Kite Pharma.
Public Labs, Corporate Gains: Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Public Labs, Corporate Gains: Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Dr. Steven Rosenberg, left, who has led the surgery branch at the National Cancer Institute for 42 years, and Dr. Arie Belldegrun, the founder of Kite Pharma.
Public Labs, Corporate Gains: Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Public Labs, Corporate Gains: Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits

Dr. Steven Rosenberg, left, who has led the surgery branch at the National Cancer Institute for 42 years, and Dr. Arie Belldegrun, the founder of Kite Pharma.
Apple and Nokia Battle Over Cellphone Patents

Apple and Nokia Battle Over Cellphone Patents

A man, center, looks at his cellphone in London. Phone pioneers are still trying to profit from an industry they no longer lead.
Apple and Nokia Battle Over Cellphone Patents

Apple and Nokia Battle Over Cellphone Patents

A man, center, looks at his cellphone in London. Phone pioneers are still trying to profit from an industry they no longer lead.
undefined